arrow
Back
A

Aung Naing

investigational cancer therapeutics

74H-index
1.1KPaper Count
2.3WCitation Count
Published Papers 305
Publication Date
Biomarker study of pembrolizumab in patients with advanced rare cancers
err2026-06-16
err0
errOAAI
errAung Naing; Xiqi Li; Qi Wang; Xiangjun (Jun) Tian; Sharjeel Sabir; Priya R. Bhosale; Mohamed H. Derbala; Bettzy Stephen; Mingxuan Xu; Joud Hajjar; Serdar A. Gurses; Yali Yang; Hassan Ahmed Momin; Ignacio Ivan Wistuba; Anas Alshawa; Kenna R. Shaw; Abdulrazzak Zarifa; Gopal Singh; Renganayaki Krishna Pandurengan; Gabriela Maria Raso
errShare
errSave
Concordance analysis of DNA and RNA profiling: The MD Anderson IMPACT2 study in precision oncology
err2026-02-24
err0
errOAAI
errStephanie T. Schmidt; Mehmet A. Baysal; Siqing Fu; David S. Hong; Sarina A. Piha-Paul; Aung Naing; Jordi Rodon Ahnert; Timothy A. Yap; Ecaterina Elena Dumbrava; Jennifer Beck; Funda Meric-Bernstam; Apostolia Maria Tsimberidou
errShare
errSave
Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson
err2026-01-13
err0
errOAAI
errJeong Uk Lim; Heather Y. Lin; Lei Kang; Hung Le; Tin-Yun Tang; Stephane Champiat; Ecaterina Elena Dumbrava; Xiuning Le; Aung Naing; Sarina A. Piha-Paul; Jordi Rodon Ahnert; Apostolia Maria Tsimberidou; Timothy A. Yap; Siqing Fu; Funda Meric-Bernstam; David S. Hong
errShare
errSave
Inducible T-Cell Co-Stimulator (ICOS) and ICOS Ligand: Dealing With a Two-Faced Cancer Immunoregulatory System
err2025-12-31
err0
errOAAI
errNikanjam, Mina; Kato, Shumei; Nishizaki, Daisuke; Miyashita, Hirotaka; Pabla, Sarabjot; Nesline, Mary K.; Ko, Heidi; Conroy, Jeffrey M.; Naing, Aung; Kurzrock, Razelle
errShare
errSave
Phase I trial of neratinib plus palbociclib in advanced cancers with HER family alterations
err2025-11-11
err0
errOAAI
errS.A. Piha-Paul; C. Tseng; H.T. Tran; S. Fu; E.E. Dumbrava; T.A. Yap; A. Naing; J. Lim; M.B. Murphy; D.L. Ramirez; P.T. Soliman; A.K. Sood; F. Meric-Bernstam
errShare
errSave
Replication-Competent, Tumor-Specific Immuno-Gene Vectors Allow for Exchange of Transgenes and Lead to Viral Persistence Following IV Administration
err2025-11-01
err0
errOAAI
errRosen, Lee S.; Ottensmeier, Christian; Hawkins, Maria; Naing, Aung; Sonpavde, Guru; Van Tine, Brian A.; Parkes, Eileen E.; O'cathail, Sean M.; Ji, Rui-Ru; Thomas, Matthew; Stacey, Andrea; Sasso, Maria Stella; Rosen, Oliver
errShare
errSave
Phase 2 Study of Monotherapy with Pembrolizumab for Advanced Adrenocortical Carcinoma
err2025-11-01
err0
PREAI
errChahla, Brenda; Stephen, Bettzy; Song, Juhee; Balderrama-Brondani, Vania; Yaylaci, Feyza; Campbell, Matthew T.; Naing, Aung; Habra, Mouhammed Amir
errShare
errSave
Autoantibody profiling to predict response to the anti-PD-1 therapy, pembrolizumab, in rare tumors
err2025-08-05
err0
errOAAI
errM.H. Derbala; J. Hajjar; B. Stephen; S.A. Gurses; E. Kwiatkowski; P. Budde; H.-D. Zucht; M. Bräutigam; A.-S. Lindemann; B.A. Abhari; M.A. Gouda; L. Castillo; A. Zarifa; J.A. How; E. Rodriguez; J.T. Moyers; D.S. Hong; S. Fu; F. Meric-Bernstam; A. Naing
errShare
errSave
ICOS and ICOS ligand: expression patterns and outcomes in oncology patients
err2025-04-24
err0
errOAAI
errMina Nikanjam; Shumei Kato; Daisuke Nishizaki; Donald A. Barkauskas; Sarabjot Pabla; Mary K. Nesline; Jeffrey M. Conroy; Aung Naing; Razelle Kurzrock
errShare
errSave
First-in-human phase I study to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and antitumor activity of PF-07209960 in patients with advanced or metastatic solid tumors
err2025-03-01
err0
errOAAI
errNaing, A.; Mckean, M.; Rosen, L. S.; Sommerhalder, D.; Shaik, N. M.; Wang, I. -m.; Le Corre, C.; Kern, K. A.; Mishra, N. H.; Pal, S. K.
errShare
errSave
A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignancies
err2025-03-01
err0
PREAI
errAhmed, Jibran; Knisely, Anne; Torrado, Carlos; Stephen, Bettzy; Yang, Yali; Song, Juhee; Alshawa, Anas; Zarifa, Abdulrazzak; Jhingran, Anuja; Koay, Eugene J.; Morris, Van Karlyle; Javle, Milind; Wolff, Robert A.; Meric-Bernstam, Funda; Pant, Shubham; Rodon, Jordi; Naing, Aung
errShare
errSave
Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single-center, multi-arm phase Ib study (vol 40, pg 290, 2022)
err2025-02-20
err0
errOAAI
errThein, Kyaw Z.; Karp, Daniel D.; Tsimberidou, Apostolia; Gong, Jing; Sulovic, Selma; Shah, Jatin; Milton, Denai R.; Hong, David S.; Janku, Filip; Mcquinn, Lacey; Stephen, Bettzy A.; Colen, Rivka; Carter, Brett W.; Yap, Timothy A.; Piha-Paul, Sarina A.; Fu, Siqing; Meric-Bernstam, Funda; Naing, Aung
errShare
errSave
Determination of nuclear charge radius by extreme-ultraviolet spectroscopy of Na-like ions
err2025-02-03
err0
errOAAI
errHosier, A.; Dipti; Blundell, S. A.; Lapierre, A.; Silwal, R.; Gwinner, G.; Tan, J. N.; Naing, A.; Gillaspy, J. D.; Yang, Y.; Szypryt, P.; O'Neil, G.; Staiger, H.; Dreiling, J. M.; Villari, A. C. C.; Angeli, I.; Ralchenko, Yu.; Takacs, E.
errShare
errSave
Phase I trial of the combination of the pan-ErbB inhibitor neratinib and mTOR inhibitor everolimus in advanced cancer patients with ErbB family gene alterations
err2025-02-01
err0
errOAAI
errPiha-Paul, S. A.; Tseng, C.; Tran, H. T.; Naing, A.; Dumbrava, E. E.; Karp, D. D.; Rodon, J.; Yap, T. A.; Raghav, K. P.; Damodaran, S.; Le, X.; Soliman, P. T.; Lim, J.; Meric-Bernstam, F.
errShare
errSave
A phase 2 basket study of talabostat, a small-molecule inhibitor of dipeptidyl peptidases, administered in combination with pembrolizumab in patients with advanced solid cancers
errCANCER
IF5.1
err2025-01-23
err0
PREAI
errAhmed, Jibran; Janku, Filip; Karp, Daniel D.; Piha-Paul, Sarina A.; Tsimberidou, Apostolia M.; Yap, Timothy Anthony; Stephen, Bettzy; Yang, Yali; Gurses, Serdar; Liu, Qian; Song, Juhee; Meric-Bernstam, Funda; Naing, Aung
errShare
errSave
Phase I dose escalation study of IO-108, an anti-LILRB2 antibody, in patients with advanced solid tumors
err2024-11-20
err0
errOAAI
errTaylor, Matthew H.; Naing, Aung; Powderly, John; Woodard, Paul; Chung, Luke; Lin, Wen Hong; Tian, Hongyu; Siemers, Nathan; Xiang, Hong; Deng, Rong; Hong, Kyu; Valencia, Donna; Huang, Tao; Zhu, Ying; Liao, X. Charlene; Schebye, Xiao Min; Patel, Manish R.
errShare
errSave
First-in-human clinical outcomes with NG-350A, an anti-CD40 expressing tumor-selective vector designed to remodel immunosuppressive tumor microenvironments
err2024-10-15
err0
errOAAI
errNaing, Aung; Khalil, Danny; Rosen, Oliver; Camidge, D. Ross; Lillie, Tom; Ji, Rui-Ru; Stacey, Andrea; Thomas, Matthew; Rosen, Lee
errShare
errSave
ENIGMA OF SHOCK
errCHEST
IF8.6
err2024-10-01
err0
PREAI
errMoen, Spencer; Naing, Aung; Qiao, Xian
errShare
errSave
A phase Ia/Ib dose-escalation/expansion study of NPX887 in subjects with solid tumor malignancies known to express HHLA2/B7-H7
err2024-09-01
err0
PREAI
errCheng, H.; Rivera, I. I. Rodriguez; McDermott, D. F.; Spira, A. I.; Ged, Y.; Liu, J.; Ji, Y.; Rausch, M.; Hashambhoy-Ramsay, Y.; Kis-Toth, K.; Gandhi, L.; Naing, A.
errShare
errSave